Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

Patients treated with dupilumab have shown significant improvements ... based on individual patient profiles and the underlying mechanisms of their disease. Chronic Rhinosinusitis (CRS): A long ...

Sanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... The data showed strong evidence of mechanism and antitumor activity in multiple tumor types shown to be ...